The price of Curaleaf has set back significantly since its impressive rise in September. Soon, however, it should continue, as the price has now reached the green target zone between CAD 5.50 and CAD 4.33, where we locate the low of the green wave 2. Following the low, there should then be significant gains again with the further green five-wave move, reaching CAD 12.
Pretty had to find a more beautiful chart. Looking for the break of the falling wedge for confirmation.
DAILY CHART CURA forming a wedge.It can move sideways a bit until next earnings on NOVEMBER 23. November 23rd is near the edge of the wedge, when multi-day breakout can happen. With the thickest part of the wedge measured, and cloned (see the purple slanted line) it should reach the target of $17.90. About a 50-60% return from the bottom of the wedge.
Or, possibly this pattern plays out as a bullish flag. The KST is displaying a bearish cross where I have placed the red downward pointing finger. Keep an eye on the DMI in the upcoming trading days, if there's a bullish cross it would be very note-worthy for the bullish narrative. Something similar to what happened where I've placed the green fingers. The...
Hello traders, this thing is strongly bullish now but its about to curve downward. I see the TOP forming. Get ready for the shorts.
It's possible this pattern plays out bullishly as a Bull Flag, there's a noticeable divergence on the RSI, we've seen higher lows in the RSI but the share price has basically chopped sideways. On the KST there's been a bearish cross.
Focused on hemoderivatives (blood plasma), Grifols is great value by most of investors. Even though the company might be one day spitted by any scandal on how it is gathering the plasma in the US, americans have got a high stake on it and today it is focusing on an hyperimmune immunoglobulin with specific antibodies against the SARS-CoV-2 virus. Grifols estimated...
Evening Traders, Today’s Technical Analysis – CURA – holding a key support with the current volume clearly declining, a move will be imminent with a subsequent influx. Points to consider, - Macro trend bearish - Resistance confluence - Structural support being tested - RSI above 50 - Stochastics projected down - Declining volume CURA’s overall trend is...
Is Curaleaf going to shake off the FUD from the FDA & continue crush the U.S market. I think so, although they may have stepped over some boundaries with promotion / labeling & making claims on some of their cbd products, it doesn't change the position they have in the U.S with distribution. It looks like CURA may have found a double bottom? Time will tell per usual.
Closed the gap, in the GZ, fibs lininging up, bull DIV... not asking for ATH but some kinda reaction would be awesome! Never know.
Reaction! The PA is not quite in the fib projection for a fif so 1 more leg down would not surprise.
waiting for a reaction though
maybe one of these 3,... but I aint Marty Mcfly... Im Marty McHigh!!!!!!!
CURA is a the Cannacord conference Monday. Could be a good news release and a 10% day.